BRIEF published on 10/25/2024 at 08:08, 27 days 6 hours ago EXEL Industries: Annual financial results 2023–2024 Growth Industry Turnover Agricultural Spraying Beetroot Harvesting
BRIEF published on 08/29/2024 at 10:29, 2 months 23 days ago EXEL Industries: Number of Shares and Voting Rights as of July 31, 2024 Shareholders Voting Rights Shares AMF Regulation EXEL Industries
PRESS RELEASE published on 08/29/2024 at 10:24, 2 months 23 days ago EXEL Industries: Number of shares and voting rights as of 07.31.2024 Press release by EXEL Industries, a French Société Anonyme with a share capital of €16,969,750. Details on total number of shares and voting rights as per AMF regulation Share Capital Voting Rights French Société Anonyme AMF Regulation EXEL Industries
BRIEF published on 07/23/2024 at 08:20, 3 months 29 days ago EXEL Industries: 3rd quarter 2023-2024 turnover up 2.1% Agriculture Industry Turnover EXEL Industries Q3 2023-2024
PRESS RELEASE published on 07/23/2024 at 08:15, 3 months 29 days ago EXEL Industries : Third quarter 2023–2024 sales up 2.1% EXEL Industries Group reports 2.1% revenue growth in Q3 2023-2024. Operational overview and 2023-2024 outlook in agricultural, leisure, and industry sectors Revenue Growth EXEL Industries Q3 2023-2024 Operational Overview 2023-2024 Outlook
BRIEF published on 07/08/2024 at 18:38, 4 months 12 days ago EXEL Industries: Number of Shares and Voting Rights as of 30 June 2024 Voting Rights Shares Financial Update AMF Regulation EXEL Industries
PRESS RELEASE published on 07/08/2024 at 18:33, 4 months 12 days ago EXEL Industries: Number of shares and voting rights as of 06.30.2024 EXEL Industries, a French Societe Anonyme with a share capital of €16,969,750, discloses its total number of shares and voting rights as per Article 223-16 of the AMF regulation Share Capital Voting Rights French Société Anonyme AMF Regulation EXEL Industries
BRIEF published on 05/24/2024 at 08:04, 5 months 28 days ago EXEL Industries: First Half 2023-2024 Results Financial Results EBITDA Revenue Outlook EXEL Industries
PRESS RELEASE published on 05/24/2024 at 07:59, 5 months 28 days ago EXEL Industries: first half 2023–2024 results EXEL Industries reports a 2.0% revenue increase in the first half of 2023-2024, with EBITDA growing to €30.5 million. Net income remains stable at €4.7 million Financial Results Revenue Increase EBITDA Growth EXEL Industries Net Debt
BRIEF published on 05/07/2024 at 20:35, 6 months 13 days ago EXEL Industries details its voting rights and shares as of April 30, 2024 AMF Regulations EXEL Industries EXEL Voting Rights Social Capital EXEL Industries Shares
Published on 11/21/2024 at 14:00, 17 minutes ago Demotech, Inc. Assigns a Financial Stability Rating(R) of A, Exceptional, to Steadily Insurance Company
Published on 11/21/2024 at 14:00, 17 minutes ago Montara Raises $5.4M to Help Organizations Deliver Better Data Products Faster
Published on 11/21/2024 at 14:00, 17 minutes ago Tevir Capital LP Ltd. Updates Early Warning Reporting in Respect of VerticalScope Holdings Inc.
Published on 11/21/2024 at 13:30, 47 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 12:35, 1 hour 42 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 2 hours 2 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 7 hours 19 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 57 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 32 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 32 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
